Growth rate-corrected (GR) dose-response metrics across a panel of 71 breast cancer cell lines treated with a library of small molecule and antibody perturbagens. Dataset 2 of 4: Calculated dose-response metrics. - Dataset (ID:20269)

Filter results: >>>>
Cell Clinical Subtype Transcriptional Subtype Small Molecule Antibody Perturbagen Target Perturbagen Class Biological Replicate ID Conc Unit GR50 GEC50 GRmax GRinf GR Hill Coefficient GR_AOC GR r2 Nominal Division Rate
SUM225CWN
HER2amp
Basal A
XRP44X
ELK3
MAPK
12098.157
uM
inf
1.40390
0.3594 0.5068 4.9916 0.1832
0.8708
1.3067
SUM225CWN
HER2amp
Basal A
XRP44X
ELK3
MAPK
10579.139
uM
2.020
1.80530
0.1277 0.1416 2.9630 0.3124
0.9786
1.1260
SUM225CWN
HER2amp
Basal A
ZM-447439
AURK
AURK
10579.138
uM
inf
inf
0.2201 0.2201 0.0000 0.2647
0.4560
0.9860
SUM225CWN
HER2amp
Basal A
ZM-447439
AURK
AURK
12098.16
uM
13.38460
65.75340
-0.2414 -1.0000 0.6902 0.2552
0.8253
0.9575
SUM229PE
TNBC
-
(Z)-4-Hydroxytamoxifen
ESR1
7536.016
uM
1.33320
1.43040
-0.3635 -0.2106 5.0000 0.4917
0.8761
0.6413
SUM229PE
TNBC
-
(Z)-4-Hydroxytamoxifen
ESR1
9860.019
uM
7.90460
30.21810
-0.8836 -1.0000 0.8193 0.3487
0.9244
1.6927
SUM229PE
TNBC
-
17-AAG
HSP90
HSP90
9860.037
uM
0.02383
0.13802
-0.8181 -0.6015 0.4496 0.7806
0.8992
1.6767
SUM229PE
TNBC
-
17-AAG
HSP90
HSP90
7536.05
uM
0.03109
0.06441
-0.6473 -0.6005 1.0833 0.9322
0.9561
0.9494
SUM229PE
TNBC
-
2-deoxyglucose
13062.177
uM
1113.5250
980.09460
0.1793 0.1197 2.1446 0.1413
0.7486
1.7820
SUM229PE
TNBC
-
2-deoxyglucose
13009.177
uM
737.68510
1000.00000
0.0596 -0.1957 1.0856 0.1991
0.7659
1.2366
SUM229PE
TNBC
-
5-DFUR
TYMS
TYMS
11058.143
uM
122.56230
1000.00000
-0.1077 -0.6589 0.4004 0.3527
0.9720
2.3374
SUM229PE
TNBC
-
5-FU
TYMS
TYMS
9860.017
uM
101.33310
457.99020
-0.6201 -0.7786 0.6224 0.5379
0.9953
1.7158
SUM229PE
TNBC
-
Afatinib
EGFR/HER2
ErbB
11058.158
uM
1.76370
5.52960
-0.8088 -1.0000 0.9614 0.4777
0.9540
2.1018
SUM229PE
TNBC
-
AG1024
IGF1R
RTK
7537.066
uM
26.08790
6.20780
0.4820 0.3992 1.1154 0.1176
0.9213
2.0549
SUM229PE
TNBC
-
AG1024
IGF1R
RTK
7535.066
uM
5.15860
4.60680
0.2165 0.2160 5.0000 0.1733
0.9238
0.7812
SUM229PE
TNBC
-
AG1478
EGFR
ErbB
9860.019
uM
inf
0.66920
0.6943 0.6826 1.3958 0.1614
0.7691
1.6927
SUM229PE
TNBC
-
AG1478
EGFR
ErbB
7536.016
uM
7.57380
8.19850
-0.4001 -0.2432 5.0000 0.4156
0.8150
0.6413
SUM229PE
TNBC
-
AS-252424
PI3K
PI3K
11058.158
uM
inf
1.27320
0.4597 0.6173 1.6385 0.1628
0.6573
2.1018
SUM229PE
TNBC
-
Baicalein
Lipoxygenase
Metabolism
11058.072
uM
inf
999.9990
0.7363 0.5109 0.1359 0.1245
0.6645
2.3023
SUM229PE
TNBC
-
Baicalein
Lipoxygenase
Metabolism
7535.072
uM
50.49310
39.54220
0.3408 0.3400 4.6606 0.0824
0.9254
1.0923
SUM229PE
TNBC
-
Bortezomib
Proteasome
Proteasome
7535.074
uM
0.75051
3.36660
-0.9254 -1.0000 0.7320 0.6555
0.9722
1.0507
SUM229PE
TNBC
-
Bortezomib
Proteasome
Proteasome
7535.074
uM
0.75051
3.36660
-0.9254 -1.0000 0.7320 0.6555
0.9722
1.0507
SUM229PE
TNBC
-
Bortezomib
Proteasome
Proteasome
14807.203
uM
0.00365
0.00535
-0.7798 -0.7104 2.3037 1.2491
0.9925
1.7148
SUM229PE
TNBC
-
Bortezomib
Proteasome
Proteasome
14807.203
uM
0.00365
0.00535
-0.7798 -0.7104 2.3037 1.2491
0.9925
1.7148
SUM229PE
TNBC
-
Bortezomib
Proteasome
Proteasome
7537.074
uM
0.02770
0.04580
-0.7839 -0.7561 1.8316 1.1238
0.9963
2.0080